- Stocks
- Healthcare
- NASDAQ: AMED

Price (delayed)

$244.8

Market cap

$7.97B

P/E Ratio

39.68

Dividend/share

N/A

EPS

$6.17

Enterprise value

$8.23B

The net income has soared by 58% YoY and by 10% QoQ

AMED's EPS has soared by 56% YoY and by 9% from the previous quarter

The quick ratio has decreased by 45% YoY but it has increased by 5% QoQ

The company's debt fell by 29% YoY but it rose by 9% QoQ

What are the main financial stats of AMED

Market
Valuations
Earnings

Shares outstanding

32.57M

Market cap

$7.97B

Enterprise value

$8.23B

Price to earnings (P/E)

39.68

Price to book (P/B)

10.2

Price to sales (P/S)

3.79

EV/EBIT

33.49

EV/EBITDA

25.99

EV/Sales

3.89

Revenue

$2.12B

EBIT

$245.76M

EBITDA

$316.71M

Free cash flow

$331.51M

Per share
Balance sheet
Liquidity

EPS

$6.17

Free cash flow per share

$10.11

Book value per share

$23.99

Revenue per share

$64.58

TBVPS

$17.4

Total assets

$1.57B

Total liabilities

$783.64M

Debt

$335.12M

Equity

$788.15M

Working capital

-$75.63M

Debt to equity

0.43

Current ratio

0.83

Quick ratio

0.78

Net debt/EBITDA

0.81

Margins
Efficiency
Dividend

EBITDA margin

15%

Gross margin

43.5%

Net margin

9.5%

Operating margin

11.5%

Return on assets

12.6%

Return on equity

26.2%

Return on invested capital

60.1%

Return on capital employed

22%

Return on sales

11.6%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the Amedisys stock price performed over time

Intraday

-0.85%

1 week

-5.72%

1 month

-4.74%

1 year

36.64%

YTD

-16.54%

QTD

-7.55%

How have Amedisys's revenue and profit performed over time

Revenue

$2.12B

Gross profit

$920.14M

Operating income

$244.25M

Net income

$201.68M

Gross margin

43.5%

Net margin

9.5%

The net income has soared by 58% YoY and by 10% QoQ

The company's net margin rose by 48% YoY and by 7% QoQ

AMED's operating income is up by 38% year-on-year and by 11% since the previous quarter

The company's operating margin rose by 29% YoY and by 8% QoQ

What is Amedisys's growth rate over time

What is Amedisys stock price valuation

P/E

39.68

P/B

10.2

P/S

3.79

EV/EBIT

33.49

EV/EBITDA

25.99

EV/Sales

3.89

AMED's EPS has soared by 56% YoY and by 9% from the previous quarter

The P/E is 16% below the last 4 quarters average of 47.8 and 7% below the 5-year quarterly average of 42.9

The P/B is 54% more than the 5-year quarterly average of 6.7 but 2% less than the last 4 quarters average of 10.5

AMED's equity is up by 16% year-on-year but it is down by 2.6% since the previous quarter

The P/S is 74% more than the 5-year quarterly average of 2.2 but 2.1% less than the last 4 quarters average of 3.9

Amedisys's revenue has increased by 7% YoY and by 2.2% from the previous quarter

How efficient is Amedisys business performance

The ROIC has soared by 69% YoY and by 29% from the previous quarter

The ROE has grown by 28% YoY and by 6% from the previous quarter

The ROA is up by 27% year-on-year and by 8% since the previous quarter

AMED's ROS is up by 26% YoY and by 9% from the previous quarter

What is AMED's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for AMED.

How did Amedisys financials performed over time

AMED's total assets is 101% higher than its total liabilities

The quick ratio has decreased by 45% YoY but it has increased by 5% QoQ

The current ratio has decreased by 44% YoY but it has increased by 5% QoQ

The company's debt is 57% lower than its equity

The debt to equity has contracted by 39% YoY but it has grown by 13% from the previous quarter

The company's debt fell by 29% YoY but it rose by 9% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.